Table 3.
Characteristics of the microbiome in cancer patients treated with immune check point inhibitors (ICIs).
| Cancer | Microbes related with response to ICI treatment | References |
|---|---|---|
| Metastatic melanoma | B. fragilis and/or B. thetaiotaomicron, Burkholderiales species | (193) |
| Metastatic melanoma | Faecalibacterium genus and other Firmicutes | (194) |
| Metastatic melanoma | Enterococcus faecium, Collinsella aerofaciens, Bifidobacterium adolescentis, Klebsiella pneumoniae, Veillonella parvula, Parabacteroides merdae, Lactobacillus species, and Bifidobacterium longum | (195) |
| Non-small cell lung carcinoma | Ruminococcaceae, Faecalibacterium, specifically Ruminococcae, Alistipes, and Eubacterium species | (196) |
| Renal cell carcinoma | Ruminococcaceae, Faecalibacterium, specifically Ruminococcae, Alistipes, and Eubacterium species | (196) |